Search BRITE hierarchies
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A04 ANTIEMETICS AND ANTINAUSEANTS
A04A ANTIEMETICS AND ANTINAUSEANTS
A04AD Other antiemetics
A04AD01 Scopolamine [DG:DG00065]
D00138 Scopolamine (INN) <US>
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CM Other hypnotics and sedatives
N05CM05 Scopolamine [DG:DG00065]
D00138 Scopolamine (INN) <US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01F MYDRIATICS AND CYCLOPLEGICS
S01FA Anticholinergics
S01FA02 Scopolamine [DG:DG00065]
D00138 Scopolamine (INN) <US>
USP drug classification [BR:br08302]
Antiemetics
Antiemetics, Other
Scopolamine [DG:DG00065]
D00138 Scopolamine (INN)
Gastrointestinal Agents
Antispasmodics, Gastrointestinal
Scopolamine [DG:DG00065]
D00138 Scopolamine (INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Scopolamine
D00138 Scopolamine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG00065 Scopolamine
D00138 Scopolamine
Gastrointestinal agent
DG01762 Antiemetic
DG00065 Scopolamine
D00138 Scopolamine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
D00138 Scopolamine (INN) <US>
[ BRITE | KEGG2 | KEGG ]